BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 7890059)

  • 1. Endometrial effects of long-term low-dose administration of RU486.
    Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
    Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
    Kettel LM; Murphy AA; Mortola JF; Liu JH; Ulmann A; Yen SS
    Fertil Steril; 1991 Sep; 56(3):402-7. PubMed ID: 1716596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term low-dose mifepristone on reproductive function in women.
    Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
    Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors in human decidua after RU486 treatment.
    Shi WL; Wang JD; Fu Y; Zhu PD
    Fertil Steril; 1993 Jul; 60(1):69-74. PubMed ID: 8513961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression.
    Heikinheimo O; Hsiu JG; Gordon K; Kim S; Williams RF; Gibbons WE; Hodgen GD
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):179-90. PubMed ID: 9010333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).
    Kettel LM; Murphy AA; Morales AJ; Yen SS
    Am J Obstet Gynecol; 1998 Jun; 178(6):1151-6. PubMed ID: 9662295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
    Murphy AA; Castellano PZ
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the antiprogesterone RU486 (Mifepristone) on an endometrial secretory glycan: an immunocytochemical study.
    Graham RA; Li TC; Seif MW; Aplin JD; Cooke ID
    Fertil Steril; 1991 Jun; 55(6):1132-6. PubMed ID: 1709886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro.
    Jiang J; Wu RF; Wang ZH; Sun HC; Xu Z; Xiu HM
    Fertil Steril; 2002 May; 77(5):995-1000. PubMed ID: 12009357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria].
    Jiang J; Wu R; Wang Z
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):218-21. PubMed ID: 11783365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.
    Engemise SL; Willets JM; Taylor AH; Emembolu JO; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):101-6. PubMed ID: 21470761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.